Point-of-Care Approaches for Meningitis Diagnosis in a Low-Resource Setting (Southwestern Uganda): Observational Cohort Study Protocol of the "PI-POC" Trial
- PMID: 33146628
- PMCID: PMC7690656
- DOI: 10.2196/21430
Point-of-Care Approaches for Meningitis Diagnosis in a Low-Resource Setting (Southwestern Uganda): Observational Cohort Study Protocol of the "PI-POC" Trial
Abstract
Background: A timely differential diagnostic is essential to identify the etiology of central nervous system (CNS) infections in children, in order to facilitate targeted treatment, manage patients, and improve clinical outcome.
Objective: The Pediatric Infection-Point-of-Care (PI-POC) trial is investigating novel methods to improve and strengthen the differential diagnostics of suspected childhood CNS infections in low-income health systems such as those in Southwestern Uganda. This will be achieved by evaluating (1) a novel DNA-based diagnostic assay for CNS infections, (2) a commercially available multiplex PCR-based meningitis/encephalitis (ME) panel for clinical use in a facility-limited laboratory setting, (3) proteomics profiling of blood from children with severe CNS infection as compared to outpatient controls with fever yet not severely ill, and (4) Myxovirus resistance protein A (MxA) as a biomarker in blood for viral CNS infection. Further changes in the etiology of childhood CNS infections after the introduction of the pneumococcal conjugate vaccine against Streptococcus pneumoniae will be investigated. In addition, the carriage and invasive rate of Neisseria meningitidis will be recorded and serotyped, and the expression of its major virulence factor (polysaccharide capsule) will be investigated.
Methods: The PI-POC trial is a prospective observational study of children including newborns up to 12 years of age with clinical features of CNS infection, and age-/sex-matched outpatient controls with fever yet not severely ill. Participants are recruited at 2 Pediatric clinics in Mbarara, Uganda. Cerebrospinal fluid (for cases only), blood, and nasopharyngeal (NP) swabs (for both cases and controls) sampled at both clinics are analyzed at the Epicentre Research Laboratory through gold-standard methods for CNS infection diagnosis (microscopy, biochemistry, and culture) and a commercially available ME panel for multiplex PCR analyses of the cerebrospinal fluid. An additional blood sample from cases is collected on day 3 after admission. After initial clinical analyses in Mbarara, samples will be transported to Stockholm, Sweden for (1) validation analyses of a novel nucleic acid-based POC test, (2) biomarker research, and (3) serotyping and molecular characterization of S. pneumoniae and N. meningitidis.
Results: A pilot study was performed from January to April 2019. The PI-POC trial enrollment of patients begun in April 2019 and will continue until September 2020, to include up to 300 cases and controls. Preliminary results from the PI-POC study are expected by the end of 2020.
Conclusions: The findings from the PI-POC study can potentially facilitate rapid etiological diagnosis of CNS infections in low-resource settings and allow for novel methods for determination of the severity of CNS infection in such environment.
Trial registration: ClinicalTrials.gov NCT03900091; https://clinicaltrials.gov/ct2/show/NCT03900091.
International registered report identifier (irrid): DERR1-10.2196/21430.
Keywords: Uganda; central nervous system infections; children; diagnostics; global health; low-resource settings; meningitis; pediatrics.
©Giulia Gaudenzi, Elias Kumbakumba, Reza Rasti, Deborah Nanjebe, Pedro Réu, Dan Nyehangane, Andreas Mårtensson, Milly Nassejje, Jens Karlsson, John Mzee, Peter Nilsson, Stephen Businge, Edmund Loh, Yap Boum II, Helene Andersson-Svahn, Jesper Gantelius, Juliet Mwanga-Amumpaire, Tobias Alfvén. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 04.11.2020.
Conflict of interest statement
Conflicts of Interest: We declare that we have no competing financial or nonfinancial interests. RR had, prior to the commencement of the PI-POC trial, owned a smaller amount of shares (<1500 Euros) in bioMérieux, the parent company of BioFire. All shares were sold in December 2018.
Similar articles
-
Sexually Transmitted Infection Point-of-Care Testing in Resource-Limited Settings: A Narrative Review Guided by an Implementation Framework.Sex Transm Dis. 2023 Oct 1;50(10):e11-e16. doi: 10.1097/OLQ.0000000000001848. Epub 2023 Jul 4. Sex Transm Dis. 2023. PMID: 37433000 Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Rapid Diagnostic Tests to Guide Case Management of and Improve Antibiotic Stewardship for Pediatric Acute Respiratory Illnesses in Resource-Constrained Settings: a Prospective Cohort Study in Southwestern Uganda.Microbiol Spectr. 2021 Dec 22;9(3):e0169421. doi: 10.1128/Spectrum.01694-21. Epub 2021 Nov 24. Microbiol Spectr. 2021. PMID: 34817224 Free PMC article.
-
Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.Cochrane Database Syst Rev. 2021 Aug 12;8(8):CD013207. doi: 10.1002/14651858.CD013207.pub2. Cochrane Database Syst Rev. 2021. PMID: 34383961 Free PMC article. Review.
-
Introducing a New Algorithm for Classification of Etiology in Studies on Pediatric Pneumonia: Protocol for the Trial of Respiratory Infections in Children for Enhanced Diagnostics Study.JMIR Res Protoc. 2019 Apr 26;8(4):e12705. doi: 10.2196/12705. JMIR Res Protoc. 2019. PMID: 31025954 Free PMC article.
Cited by
-
Aseptic Meningitis and Its Viral Etiologies, Clinical Characteristics and Management Practices in Children: A Retrospective Hospital-Based Study From Jordan.Cureus. 2022 Apr 22;14(4):e24383. doi: 10.7759/cureus.24383. eCollection 2022 Apr. Cureus. 2022. PMID: 35611041 Free PMC article.
References
-
- GBD 2016 Meningitis Collaborators Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Dec;17(12):1061–1082. doi: 10.1016/S1474-4422(18)30387-9. https://linkinghub.elsevier.com/retrieve/pii/S1474-4422(18)30387-9 - DOI - PMC - PubMed
-
- Ramakrishnan M, Ulland A, Steinhardt L, Moïsi JC, Were F, Levine O. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med. 2009 Sep 14;7:47. doi: 10.1186/1741-7015-7-47. https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-7-47 - DOI - DOI - PMC - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous